Contact
Please use this form to send email to PR contact of this press release:
YMAB LAWSUIT ALERT: Hagens Berman, National Trial Attorneys, Encourages Y-mAbs Therapeutics (YMAB) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
TO: